Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
Author(s):
Aluwini, S.; Pos, F.; Schimmel, E.; Lin, E. van; Krol, S.; Toorn, P.P. van der; Jager, H. de; Dirkx, M.; Alemayehu, W.G.; Heijmen, B.; Incrocci, L.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-03-31
Language
English
Is part of
The Lancet Oncology (2015), Vol. 16, no. 3, p. 274-283
